Nat Rev Drug Discov · 2022
PROTAC targeted protein degraders: the past is prologue
Békés M, Langley DR, Crews CM.
Show affiliations
- Békés M — Arvinas, Inc., New Haven, CT, USA. miklos.bekes@arvinas.com.
- Langley DR — Arvinas, Inc., New Haven, CT, USA. david.langley@arvinas.com.
- Crews CM — Department of Molecular, Cellular & Developmental Biology, Yale University, New Haven, CT, USA. craig.crews@yale.edu.
35 read3 want to readRigor 3.3Novelty 2.5Impact 2.9Reprod. 2.5
Most-cited papers citing this
- Blood · 2026 · cited by 2
- Fortschr Neurol Psychiatr · 2026 · cited by 1
- Adv Sci (Weinh) · 2026 · cited by 1
- Cancer Res · 2026 · cited by 1
- Cancer Discov · 2026 · cited by 1
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.
0
0
0
0
0
0
0